We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development. In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discu...
All content for AI Uncovered is the property of Timothy Martin, Executive VP of Product at Yseop and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development. In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discu...
Oeystein Kjoersvik - Auditing AI: Quality, Compliance & the Role of GenAI in Pharma
AI Uncovered
32 minutes
7 months ago
Oeystein Kjoersvik - Auditing AI: Quality, Compliance & the Role of GenAI in Pharma
We’re excited to welcome Oeystein Kjoersvik to AI Uncovered. Oeystein leads the Generative AI program within the Quality Assurance team at Merck, where he focuses on developing AI tools and applying a quality-first approach to ensure safe, effective use of AI in GxP-regulated environments. In this episode, Tim and Oeystein delve into the challenges of adopting AI in regulated settings, the complexity of validating GenAI tools, and the transition from traditional processes to AI-augmented syst...
AI Uncovered
We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development. In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discu...
